![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.440, 2003-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Concomitant hypnosedative, donepezil use common in elderly with AD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Increased AWAREness with donepezil therapy for AD
Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Donepezil enhances cognitive function, QOL in AD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 453, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Donepezil demonstrates success throughout the AD continuum
Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Donepezil enhances cognitive function, QOL in AD
Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. :